IRMD · Iradimed Corp · Earnings Call Transcripts & Audio
Market Cap
$1.05B
Shares
12.79M
Iradimed Corp Earnings Call Transcripts
Quarterly earnings calls for Iradimed Corp (IRMD), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲22.9%
$13.41M
$3.43M
'22 Q3
22-11-03
▲25.2%
$14.86M
$3.67M
'22 Q4
23-01-19
▲25.7%
$15.48M
$3.41M
'23 Q1
23-05-04
▲26.8%
$16.13M
$4.18M
'23 Q2
23-08-03
▲23.1%
$16.50M
$5.07M
'23 Q3
23-11-03
▲17.4%
$17.45M
$4.54M
'23 Q4
24-02-08
▲13.7%
$17.60M
$4.14M
'24 Q1
24-05-02
▲11.1%
$17.93M
$4.90M
'24 Q2
24-08-01
▲11%
$18.33M
$5.05M
'24 Q3
24-10-31
▲11.1%
$19.39M
$5.15M
'24 Q4
25-02-13
▲10.9%
$19.51M
$4.69M
'25 Q1
25-05-05
▲13.8%
$20.41M
$5.77M
'25 Q2
25-08-01
▲15.7%
$21.20M
$5.58M
'25 Q3
25-11-03
▲17%
$22.69M
$6.44M
'25 Q4
26-02-10
▲12.6%
$21.98M
$5.82M
'26 Q1
26-05-01
LATEST
▲0.3%
$20.47M
$5.22M
'26 Q2
26-07-31
Earnings call
FY26 · Q2
2026-07-31
Iradimed Corp (IRMD) Q2 2026 Earnings Call Transcript
Confident tone
3870 IV Pump Production Ramp
Financial Guidance and Margin Outlook
3870 Replacement Opportunity / Channel Growth
Revenue
$20.47M
▲ 0.3% YoY Diluted EPS
$0.41
▼ 8.9% YoY Gross margin
74.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-01
Iradimed Corp (IRMD) Q1 2026 Earnings Call Transcript
Confident tone
3870 MR IV Pump Launch
MRI-Compatible IV Infusion Pump Revenue
Replacement Opportunity of 3860 Installed Base
Revenue
$21.98M
▲ 12.6% YoY Diluted EPS
$0.45
▲ 21.6% YoY Gross margin
76.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-10
Iradimed Corp (IRMD) Q4 2025 Earnings Call Transcript
Confident tone
3870 MR IV Pump Launch
Replacement Opportunity / Pump Channels
Gross Margin Outlook
Revenue
$22.69M*
▲ 17% YoY Gross margin
75.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-03
Iradimed Corp (IRMD) Q3 2025 Earnings Call Transcript
Confident tone
3870 MRI IV Pump Launch
Gross Margin and Manufacturing Transition
International Regulatory Path
Revenue
$21.20M
▲ 15.7% YoY Diluted EPS
$0.43
▲ 7.5% YoY Gross margin
77.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-01
Iradimed Corp (IRMD) Q2 2025 Earnings Call Transcript
Confident tone
3870 IV pump FDA clearance and launch
Gross margin and ASP on new pump
Quarterly and full-year revenue and earnings guidance raise
Revenue
$20.41M
▲ 13.8% YoY Diluted EPS
$0.45
▲ 18.4% YoY Gross margin
78.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-05
Iradimed Corp (IRMD) Q1 2025 Earnings Call Transcript
Confident tone
Disposables growth
Financial guidance and results
FDA 510(k) clearance for 3870 pump
Revenue
$19.51M
▲ 10.9% YoY Diluted EPS
$0.37
▲ 15.6% YoY Gross margin
76.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-13
Iradimed Corp (IRMD) Q4 2024 Earnings Call Transcript
Confident tone
Tariffs and supply chain exposure
Record financial results and growth
Pump replacement / installed base opportunity
Revenue
$19.39M*
▲ 11.1% YoY Gross margin
76.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-10-31
Iradimed Corp (IRMD) Q3 2024 Earnings Call Transcript
Confident tone
Quarterly Revenue and Earnings Records
New 510(k) Pump Progress and FDA Clearance
Sales Force Expansion Planning
Revenue
$18.33M
▲ 11% YoY Diluted EPS
$0.40
▲ 0% YoY Gross margin
77.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-01
Iradimed Corp (IRMD) Q2 2024 Earnings Call Transcript
Confident tone
Legacy 3860 pump demand and backlog
New 3870 IV pump and FDA 510(k) clearance
FMD device adoption
Revenue
$17.93M
▲ 11.1% YoY Diluted EPS
$0.38
▲ 15.2% YoY Gross margin
78.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-02
Iradimed Corp (IRMD) Q1 2024 Earnings Call Transcript
Confident tone
Disposables backlog and lead times
Financial guidance
New 3870 MRI IV Pump 510(k) submission
Revenue
$17.60M
▲ 13.7% YoY Diluted EPS
$0.32
▲ 18.5% YoY Gross margin
76.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-08
Iradimed Corp (IRMD) Q4 2023 Earnings Call Transcript
Confident tone
New 3850 MRI IV pump / FDA 510(k) submission
Gross margin outlook
2024 financial guidance
Revenue
$17.45M*
▲ 17.4% YoY Gross margin
76.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-03
Iradimed Corp (IRMD) Q3 2023 Earnings Call Transcript
Revenue
$16.50M
▲ 23.1% YoY Diluted EPS
$0.40
▲ 48.1% YoY Gross margin
77.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-03
Iradimed Corp (IRMD) Q2 2023 Earnings Call Transcript
Revenue
$16.13M
▲ 26.8% YoY Diluted EPS
$0.33
▲ 26.9% YoY Gross margin
75.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-04
Iradimed Corp (IRMD) Q1 2023 Earnings Call Transcript
Revenue
$15.48M
▲ 25.7% YoY Diluted EPS
$0.27
▲ 35% YoY Gross margin
75.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-01-19
Iradimed Corp (IRMD) Q4 2022 Earnings Call Transcript
Revenue
$14.86M*
▲ 25.2% YoY Gross margin
75.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-03
Iradimed Corp (IRMD) Q3 2022 Earnings Call Transcript
Revenue
$13.41M
▲ 22.9% YoY Diluted EPS
$0.27
▲ 35% YoY Gross margin
78.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-07-29
Iradimed Corp (IRMD) Q2 2022 Earnings Call Transcript
Revenue
$12.72M
▲ 29.7% YoY Diluted EPS
$0.26
▲ 116.7% YoY Gross margin
79.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-04-29
Iradimed Corp (IRMD) Q1 2022 Earnings Call Transcript
Revenue
$12.31M
▲ 33.5% YoY Diluted EPS
$0.20
▲ 81.8% YoY Gross margin
76.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-04
Iradimed Corp (IRMD) Q4 2021 Earnings Call Transcript
Revenue
$11.87M*
▲ 38.9% YoY Gross margin
77.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-10-29
Iradimed Corp (IRMD) Q3 2021 Earnings Call Transcript
Revenue
$10.91M
▲ 41.7% YoY Diluted EPS
$0.20
▲ 122.2% YoY Gross margin
77.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-07-30
Iradimed Corp (IRMD) Q2 2021 Earnings Call Transcript
Revenue
$9.81M
▲ 44.4% YoY Diluted EPS
$0.12
Gross margin
74.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-04-30
Iradimed Corp (IRMD) Q1 2021 Earnings Call Transcript
Revenue
$9.22M
▲ 6.3% YoY Diluted EPS
$0.11
▼ 21.4% YoY Gross margin
76.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-04
Iradimed Corp (IRMD) Q4 2020 Earnings Call Transcript
Revenue
$8.55M*
▼ 21.5% YoY Gross margin
75.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-10-30
Iradimed Corp (IRMD) Q3 2020 Earnings Call Transcript
Revenue
$7.70M
▼ 22.7% YoY Diluted EPS
$0.09
▼ 55% YoY Gross margin
74.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-07-30
Iradimed Corp (IRMD) Q2 2020 Earnings Call Transcript
Revenue
$6.79M
▼ 26.3% YoY Diluted EPS
$-0.17
▼ 200% YoY Gross margin
72.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-04-30
Iradimed Corp (IRMD) Q1 2020 Earnings Call Transcript
Revenue
$8.68M
▲ 2.8% YoY Diluted EPS
$0.14
▼ 6.7% YoY Gross margin
74.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-06
Iradimed Corp (IRMD) Q4 2019 Earnings Call
Revenue
$10.89M*
▲ 30.6% YoY Gross margin
74.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–27 of 27 earnings calls
Key facts
CIK
1325618
CUSIP
46266A109
13F (30d)
58 filings
58 filers
Visit website
Investor relations